No Detail Found!

Correlation analysis of quality of life (QoL) and area in psoriatic patients

Author(s)
Qandeel-e-Arsh Department of Biotechnology, University of Agriculture, Faisalabad, Pakistan
Abstract
Psoriasis is a chronic inflammatory disorder, involving TH17 cells. The disease is characterized by patches of scaly skin associated with itching. The patients are influenced psychologically and emotionally upon the appearance of symptoms which differs in respect to area and severity. Consequently, the present study was designed to evaluate correlation between area severity and its effect on life quality of patients. The area severity is measured by Psoriasis Area and Severity Index (PASI) and the quality of life of the patients is determined by the Dermatology Life Quality Index (DLQI). A total of 164 patients and 164 controls were enrolled for this purpose. The Pearson-Chi square value of PASI and DLQI score is 0.002 indicating an association amongst both. A significant difference was present among the DLQI values of cases and controls with the controls showing low score and higher values scored by patients. In addition, Psoriatic patients are observed to have a high body mass index, occurring usually in late teens and the early fifties. Females are observed to carry high DLQI scores without being influenced by age. Thus, the study found out associations amongst patient life quality, the severity of psoriasis in an individual along with additional parameters such as age, BMI and gender. The significance of the study is attributed to a dearth of research carried out for psoriatic patients based on a statistical nature.
Publication Details
Page(s) 415-434
DOI DOI not available
Published Journal: Journal of Natural & Applied Sciences Pakistan, Volume: 2, Issue: 2, Year: 2020

Request the full text from PASTIC

Keywords
Psoriasis, Psoriasis, Psoriasis, Psoriasis Area and Severity Index (PASI), Dermatology life quality index (DLQI)
References
. .CARD14 are novel caspase recruitment domain (CARD)/membrane-associated guanylate kinase (MAGUK) family members that interact with BCL10 and activate NF-κB. Journal of Biological Chemistry, 276(15) : 11877-11882.
Bhosle M. J.,Kulkarni A.,Feldman S. R.,Balkrishnan R. .2006 .Quality of life in patients with psoriasis. Health and quality of life outcomes, 4(1) : 35.
Busch A. L.,Landau J. M.,Goldberg M. N.,L. H. M. N. .2012 .Pediatric psoriasis. Skin Therapy Lett, 17(1) : 5-7.
Cancino-Díaz J. C.,Reyes-Maldonado E.,Bañuelos-Pánuco C. A.,JiménezZamudio L.,García-Latorre E.,Cancino-Díaz M. E.,ParedesCabrera G. .2002 .Interleukin-13 receptor in psoriatic keratinocytes: overexpression of the mRNA and underexpression of the protein. Journal of investigative dermatology, 119(5) : 1114-1120.
Cargill M.,Schrodi S. J.,Chang M.,Garcia V. E.,Brandon R.,Callis K. P.,Leong D. U. .2007 .A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. The American Journal of Human Genetics, 80(2) : 273-290.
Declercq Dubois,Pouliot S.,R. S. .2013 .Promising new treatments for psoriasis. The Scientific World Journal, : .
Dufour D. N.,Emtestam L.,Jemec G. B. .2014 .Hidradenitis suppurativa: a common and burdensome, yet underrecognised, inflammatory skin disease. Postgraduate Medical Journal, 90(1062) : 216-221.
Ejaz A.,Raza N.,Iftikhar N.,Iftikhar A.,Farooq M. .2009 .Presentation of early onset psoriasis in comparison with late onset psoriasis: A clinical study from Pakistan. Indian Journal of Dermatology, 75(1) : 36.
Ejaz A.,Suhail M.,Iftikhar A. .2016 .Psoriasis in Pakistani population: Associations, comorbidities, and hematological profile. Journal of Pakistan Association of Dermatology, 23(1) : 42-46.
Elghandour T. M.,Youssef S. E. S.,Aly D. G.,Elhameed A.,Said M.,Moneim A.,Mostafa M. .2013 .Effect of narrow band ultraviolet B therapy versus methotrexate on serum levels of interleukin-17 and interleukin-23 in Egyptian patients with severe psoriasis. Dermatology research and practice, : .
Fredriksson T.,Pettersson U. .1978 .burden in patients treated with biological therapies. Journal of the European Academy of Dermatology and Venereology, 28(3) : 333-337.
GUPTA M. A.,Gupta A. K. .1995 .Age and gender differences in the impact of psoriasis on quality of life. International journal of Dermatology, 34(10) : 700-703.
Guttman‐Yassky E.,Krueger J. G.,Lebwohl M. G. .2018 .Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment. Experimental dermatology, 27(4) : 409-417.
Hahn H. B.,Melfi C. A.,Chuang C. A.,Lewis C. W.,Gonin R.,Hanna M. P.,Farmer E. R. .2001 .Use of the Dermatology Life Quality Index (DLQI) in a midwestern US urban clinic. Journal of the American Academy of Dermatology, 45(1) : 44-48.
Hawkes J. E.,Chan T. C.,Krueger J. G. .2017 .Psoriasis pathogenesis and the development of novel targeted immune therapies. Journal of Allergy and Clinical Immunology, 140(3) : 645-653.
He Z.,Lu C.,Basra M. K. A.,Ou A.,Yan Y.,Li L. .2013 .Psychometric properties of the Chinese version of Dermatology Life Quality Index (DLQI) in 851 Chinese patients with psoriasis. Journal of the European Academy of Dermatology and Venereology, 27(1) : 109-115.
Hijnen D.,Knol E. F.,Gent Y. Y.,Giovannone B.,Beijn S. J.,Kupper T. S.,Clark R. A. .2013 .CD8+ T cells in the lesional skin of atopic dermatitis and psoriasis patients are an important source of IFN-γ. . Journal of Investigative Dermatology, 133(4) : 973-979.
Javaria M,Gary G,Kathleen M,Dina C,Andrew M .2013 .Chio F Treatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort study. BMC Dermatol, 13 : 9.
Kasumagić-Halilović E.,Prohić A.,Begović B. .2010 .TrichoScan as a method to determine hair root pattern in patients with scalp psoriasis. Acta dermatovenerologica Croatica, 18(3) : 0-0.
Kauffman C. L.,Aria N.,Toichi E.,McCormick T. S.,Cooper K. D.,Gottlieb A. B.,Pendley C. E. .2004 .A phase I study evaluating the safety, pharmacokinetics, and clinical response of a human IL-12 p40 antibody in subjects with plaque psoriasis. Journal of Investigative Dermatology, 123(6) : 1037-1044.
Lewis V.,Finlay A. Y. .2004 .10 years experience of the Dermatology Life Quality Index (DLQI). In Journal of Investigative Dermatology Symposium Proceedings, 9(2) : 169-180.
Lin T. Y.,See L. C.,Shen Y. M.,Liang C. Y.,Chang H. N.,Lin Y. K. .2011 .Quality of life in patients with psoriasis in northern Taiwan. Chang Gung Med, 34(2) : 186-96.
Ljosaa T. M.,Stubhaug A.,Mork C.,Moum T.,Wahl A. K. .2013 .Improvement in psoriasis area and severity index score predicts improvement in skin pain over time in patients with psoriasis. Acta dermato-venereologica, 93(3) : 330-334.
Mattei P. L.,Corey K. C.,Kimball A. B. .2014 .Psoriasis Area Severity Index (PASI) and the Dermatology Life Quality Index (DLQI): the correlation between disease severity and psychological. , : .
Mazlin M. B.,Chang C. C.,Baba R. .2012 .Comorbidities associated with psoriasisdata from the malaysian psoriasis registry. The Medical journal of Malaysia, 67(5) : 518-521.
Rashmi R.,Yuti A. M.,Basavaraj K. H. .2012 .Enhanced ferritin/iron ratio in psoriasis. The Indian journal of medical research, 135(5) : 662.
REiCh ,Orda A.,WiśniCka B.,SzEPiEtoWSki J. C. .2007 .Plasma neuropeptides and perception of pruritus in psoriasis. Acta dermatovenereologica, 87(4) : 299-304.
Reich K.,Armstrong A. W.,Foley P.,Song M.,Wasfi Y.,Randazzo B.,Gordon K. B. .2017 .Efficacy and safety of guselkumab, an antiinterleukin-23 monoclonal antibody, compared with adalimumab for the treatment of patients with moderate to severe psoriasis with randomized withdrawal and retreatment: Results from the phase III, double-blind, placebo-and active comparatorcontrolled VOYAGE 2 trial. Journal of the American Academy of Dermatology, 76(3) : 418-431.
Schäfer I.,Hacker J.,Rustenbach S. J.,Radtke M.,Franzke N.,Augustin M. .2010 .Concordance of the Psoriasis Area and Severity Index (PASI) and patientreported outcomes in psoriasis treatment. European Journal of Dermatology, 20(1) : 62-67.
Takahashi N.,Suzukamo Y.,Nakamura M.,Miyachi Y.,Green J.,Ohya Y.,Fukuhara S. .2006 .Japanese version of the Dermatology Life Quality Index: validity and reliability in patients with acne. Health and quality of life outcomes, 4(1) : 46.
Uva L.,Miguel D.,Pinheiro C.,Antunes J.,Cruz D.,Ferreira J.,Filipe P. .2012 .Mechanisms of action of topical corticosteroids in psoriasis. International journal of endocrinology, : .
Victoria L,Andrew Y . .Experience of the Dermatology Life Quality Index (DLQI). J Investig Dermatol Symp Proc. 2004 Mar; 9, (2) : 169-80.
Votrubova J,Juzlova K,Smerhovsky Z,Fialova J,Gopfertova D,Vojackova N,Hercogova J . .Risk factors for comorbidities in Czech psoriatic patients: Results of a hospital-based care-control study. 2013 Sep, 27 : .
Zachariae H.,Zachariae R.,Blomqvist K.,Davidsson S.,Molin L.,Mørk C.,Sigurgeirsson B. .2001 .Treatment of psoriasis in the nordic countries: a questionnaire survey from 5739 members of the psoriasis associations. Acta Derm Venereol, 81 : 116-121.
0

Citations

0

Downloads

46

Views